Daily intake of vitamin D- or calcium-vitamin D-fortified Persian yogurt drink (doogh) attenuates diabetes-induced oxidative stress: Evidence for antioxidative properties of vitamin D

Journal of Human Nutrition and Dietetics

Volumn 27, Issue SUPPL2, 2014, Pages 276-283

  Nikooyeh, B ^a   Neyestani, T R ^a   Tayebinejad, N ^a   Alavi Majd, H ^a   Shariatzadeh, N ^a   Kalayi, A ^a   Zahedirad, M ^a   Heravifard, S ^a   Salekzamani, S ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Calcium; Oxidative stress; Type 2 diabetes; Vitamin D

Indexed keywords

ANTIOXIDANT; BIOLOGICAL MARKER; CALCIUM INTAKE; VITAMIN D; YOGHURT;

ADMINISTRATION AND DOSAGE; ADULT; BLOOD; CALCIUM INTAKE; CARDIOVASCULAR DISEASE; COMPLICATION; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG EFFECTS; FEMALE; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; RANDOMIZED CONTROLLED TRIAL;

ADULT; ANTIOXIDANTS; BIOLOGICAL MARKERS; CALCIUM, DIETARY; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DOUBLE-BLIND METHOD; FEMALE; FOOD, FORTIFIED; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; VITAMIN D; YOGURT;

EID: 84897063616     PISSN: 09523871     EISSN: 1365277X     Source Type: Journal    
DOI: 10.1111/jhn.12142     Document Type: Article

References (51)

1. Argacha, J.F., Egrise, D., Pochet, S., Fontaine, D., Lefort, A., Libert, F., Goldman, S., van de Borne, P., Berkenboom, G. & Moreno-Reyes, R. (2011) Vitamin D deficiency-induced hypertension is associated with vascular oxidative stress and altered heart gene expression. J. Cardiovasc. Pharmacol. 58, 65-71.
2. Ay, L., Hoellerl, F., Ay, C., Brix, J.M., Koder, S., Schernthaner, G.H., Pabinger, I. & Schernthaner, G. (2012) Thrombin generation in type 2 diabetes with albuminuria and macrovascular disease. Eur. J. Clin. Invest. 42, 470-477.
3. Chang, C.M., Hsieh, C.J., Huang, J.C. & Huang, I.C. (2012) Acute and chronic fluctuations in blood glucose levels can increase oxidative stress in type 2 diabetes mellitus. Acta Diabetol. 49(Suppl. 1), S171-S177.
4. Codoner-Franch, P., Navarro-Ruiz, A., Fernandez-Ferri, M., Arilla-Codoner, A., Ballester-Asensio, E. & Valls-Belles, V. (2012) A matter of fat: insulin resistance and oxidative stress. Pediatr. Diabetes 13, 369-376.
5. De, C.R., Rocca, B., Marchioli, R. & Landolfi, R. (2002) Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects. Thromb. Haemost. 87, 58-67.
6. Farah, R., Shurtz-Swirski, R. & Lapin, O. (2008) Intensification of oxidative stress and inflammation in type 2 diabetes despite antihyperglycemic treatment. Cardiovasc. Diabetol. 7, 20.
7. Folli, F., Corradi, D., Fanti, P., Davalli, A., Paez, A., Giaccari, A., Perego, C. & Muscogiuri, G. (2011) The role of oxidative stress in the pathogenesis of type 2 diabetes mellitus micro- and macrovascular complications: avenues for a mechanistic-based therapeutic approach. Curr. Diabetes Rev. 7, 313-324.
8. Fu, Y., Zhang, R., Lu, D., Liu, H., Chandrashekar, K., Juncos, L.A. & Liu, R. (2010) NOX2 is the primary source of angiotensin II-induced superoxide in the macula densa. Am. J. Physiol. Regul. Integr. Comp. Physiol. 298, R707-R712.
9. Giacco, F. & Brownlee, M. (2010) Oxidative stress and diabetic complications. Circ. Res. 107, 1058-1070.
10. Gikas, A., Sotiropoulos, A., Pastromas, V., Papazafiropoulou, A., Apostolou, O. & Pappas, S. (2009) Seasonal variation in fasting glucose and HbA1c in patients with type 2 diabetes. Prim. Care Diabetes 3, 111-114.
11. Halhali, A., Figueras, A.G., Diaz, L., Avila, E., Barrera, D., Hernandez, G. & Larrea, F. (2010) Effects of calcitriol on calbindins gene expression and lipid peroxidation in human placenta. J. Steroid Biochem. Mol. Biol. 121, 448-451.
12. Hamden, K., Carreau, S., Jamoussi, K., Miladi, S., Lajmi, S., Aloulou, D., Ayadi, F. & Elfeki, A. (2009) 1alpha, 25 dihydroxyvitamin D3: therapeutic and preventive effects against oxidative stress, hepatic, pancreatic and renal injury in alloxan-induced diabetes in rats. J. Nutr. Sci. Vitaminol. 55, 215-222.
13. Hegab, Z., Gibbons, S., Neyses, L. & Mamas, M.A. (2012) Role of advanced glycation end products in cardiovascular disease. World J. Cardiol. 4, 90-102.
14. Holick, M.F. (2005) The vitamin D epidemic and its health consequences. J. Nutr. 135, 2739S-2748S.
15. Holick, M.F. (2011) Vitamin D: evolutionary, physiological and health perspectives. Curr. Drug Targets 12, 4-18.
16. Holick, M.F. (2012) Vitamin D: extraskeletal health. Rheum. Dis. Clin. North Am. 38, 141-160.
17. Holvoet, P. (2008) Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease. Verh. K. Acad. Geneeskd. Belg. 70, 193-219.
18. Izquierdo, M.J., Cavia, M., Muniz, P., de Francisco, A.L., Arias, M., Santos, J. & Abaigar, P. (2012) Paricalcitol reduces oxidative stress and inflammation in hemodialysis patients. BMC Nephrol. 13, 159.
19. Johansen, J.S., Harris, A.K., Rychly, D.J. & Ergul, A. (2005) Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc. Diabetol. 4, 5.
20. Kallay, E., Bareis, P., Bajna, E., Kriwanek, S., Bonner, E., Toyokuni, S. & Cross, H.S. (2002) Vitamin D receptor activity and prevention of colonic hyperproliferation and oxidative stress. Food Chem. Toxicol. 40, 1191-1196.
21. Kilhovd, B.K., Berg, T.J., Birkeland, K.I., Thorsby, P. & Hanssen, K.F. (1999) Serum levels of advanced glycation end products are increased in patients with type 2 diabetes and coronary heart disease. Diabetes Care 22, 1543-1548.
22. Lin, A.M., Chen, K.B. & Chao, P.L. (2005) Antioxidative effect of vitamin D3 on zinc-induced oxidative stress in CNS. Ann. N. Y. Acad. Sci. 1053, 319-329.
23. Miravet, L., Gueris, J., Redel, J., Norman, A. & Ryckewaert, A. (1981) Action of vitamin D metabolites on PTH secretion in man. Calcif. Tissue Int. 33, 191-194.
24. Moldoveanu, E., Tanaseanu, C., Tanaseanu, S., Kosaka, T., Manea, G., Marta, G. & Popwscu, L.M. (2006) Plasma markers of endothelial dysfunction in type 2 diabetics. Eur. J. Intern. Med. 17, 38-42.
25. Neyestani, T.R., Gharavi, A. & Kalayi, A. (2007a) Determination of serum 25-hydroxy cholecalciferol using high-performance liquid chromatography: a reliable tool for assessment of vitamin D status. Int. J. Vitam. Nutr. Res. 77, 341-346.
26. Neyestani, T.R., Shariatzadeh, N., Gharavi, A., Kalayi, A. & Khalaji, N. (2007b) Physiological dose of lycopene suppressed oxidative stress and enhanced serum levels of immunoglobulin M in patients with type 2 diabetes mellitus: a possible role in the prevention of long-term complications. J. Endocrinol. Invest. 30, 833-838.
27. Neyestani, T.R., Djazayery, A., Shab-Bidar, S., Eshraghian, M.R., Kalayi, A., Shariatzadeh, N., Khalaji, N., Zahedirad, M., Gharavi, A., Houshiarrad, A., Chamari, M. & Asadzadeh, S. (2013) Vitamin D receptor Fok-I polymorphism modulates diabetic host response to vitamin D intake: need for a nutrigenetic approach. Diabetes Care 36, 550-556.
28. Neyestani, T.R., Nikooyeh, B., Alavi-Majd, H., Shariatzadeh, N., Kalayi, A., Tayebinejad, N., Heravifard, S., Salekzamani, S. & Zahedirad, M. (2012) Improvement of vitamin D status via daily intake of fortified yogurt drink either with or without extra calcium ameliorates systemic inflammatory biomarkers, including adipokines, in the subjects with type 2 diabetes. J. Clin. Endocrinol. Metab. 97, 2005-2011.
29. Nikooyeh, B., Neyestani, T.R., Farvid, M., Alavi-Majd, H., Houshiarrad, A., Kalayi, A., Shariatzadeh, N., Gharavi, A., Heravifard, S., Tayebinejad, N., Salekzamani, S. & Zahedirad, M. (2011) Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial. Am. J. Clin. Nutr. 93, 764-771.
30. Nussbaum, C., Klinke, A., Adam, M., Baldus, S. & Sperandio, M. (2013) Myeloperoxidase: a leukocyte-derived protagonist of inflammation and cardiovascular disease. Antioxid. Redox Signal. 18, 692-713.
31. Prasad, A., Bekker, P. & Tsimikas, S. (2012) Advanced glycation end products and diabetic cardiovascular disease. Cardiol. Rev. 20, 177-183.
32. Riek, A.E., Oh, J. & Bernal-Mizrachi, C. (2010) Vitamin D regulates macrophage cholesterol metabolism in diabetes. J. Steroid Biochem. Mol. Biol. 121, 430-433.
33. Saintoge, S., Bang, H. & Gerber, L.M. (2009) Implications of a new definition of vitamin D deficiency in a multiracial US adolescent population: the national health and nutrition examination survey (III). Pediatrics 123, 797-803.
34. Sardar, S., Chakraborty, A. & Chatterjee, M. (1996) Comparative effectiveness of vitamin D3 and dietary vitamin E on peroxidation of lipids and enzymes of the hepatic antioxidant system in Sprague-Dawley rats. Int. J. Vitam. Nutr. Res. 66, 39-45.
35. Sasaki, S. & Inoguchi, T. (2012) The role of oxidative stress in the pathogenesis of diabetic vascular complications. Diabetes Metab. J. 36, 255-261.
36. Satoh, K. (1978) Serum lipid peroxide in cerebrovascular disorders determined by a new colorimetric method. Clin. Chim. Acta 90, 37-43.
37. Shab-Bidar, S., Neyestani, T.R., Djazayery, A., Eshraghian, M.R., Houshiarrad, A., Kalayi, A., Shariatzadeh, N., Khalaji, N. & Gharavi, A. (2012) Improvement of vitamin D status resulted in amelioration of biomarkers of systemic inflammation in the subjects with type 2 diabetes. Diabetes Metab. Res. Rev. 28, 424-430.
38. Stern, D., Yan, S.D., Yan, S.F. & Schmidt, A.M. (2002) Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings. Adv. Drug Deliv. Rev. 54, 1615-1625.
39. Stralin, P. & Marklund, S.L. (2000) Multiple cytokines regulate the expression of extracellular superoxide dismutase in human vascular smooth muscle cells. Atherosclerosis 151, 433-441.
40. Sun, X. & Zemel, M.B. (2007) 1Alpha, 25-dihydroxyvitamin D3 modulation of adipocyte reactive oxygen species production. Obesity (Silver Spring) 15, 1944-1953.
41. Talmor, Y., Golan, E., Benchetrit, S., Bernheim, J., Klein, O., Green, J. & Rashid, G. (2008) Calcitriol blunts the deleterious impact of advanced glycation end products on endothelial cells. Am. J. Physiol. Renal Physiol. 294, F1059-F1064.
42. Tuttle, K.R., Anderberg, R.J., Cooney, S.K. & Meek, R.L. (2009) Oxidative stress mediates protein kinase C activation and advanced glycation end product formation in a mesangial cell model of diabetes and high protein diet. Am. J. Nephrol. 29, 171-180.
43. Vidal, A., Sun, Y., Bhattacharya, S.K., Ahokas, R.A., Gerling, I.C. & Weber, K.T. (2006) Calcium paradox of aldosteronism and the role of the parathyroid glands. Am. J. Physiol. Heart Circ. Physiol. 290, H286-H294.
44. Wang, X.L., Adachi, T., Sim, A.S. & Wilcken, D.E. (1998) Plasma extracellular superoxide dismutase levels in an Australian population with coronary artery disease. Arterioscler. Thromb. Vasc. Biol. 18, 1915-1921.
45. Wang, L., Song, Y., Manson, J.E., Pilz, S., Marz, W., Michaelsson, K., Lundqvist, A., Jassal, S.K., Barrett-Connor, E., Zhang, C., Eaton, C.B., May, H.T., Anderson, J.L. & Sesso, H.D. (2012) Circulating 25-hydroxy-vitamin d and risk of cardiovascular disease: a meta-analysis of prospective studies. Circ. Cardiovasc. Qual. Outcomes 5, 819-829.
46. Wiersma, J.J., Meuwese, M.C., van Miert, J.N., Kastelein, A., Tijssen, J.G., Piek, J.J. & Trip, M.D. (2008) Diabetes mellitus type 2 is associated with higher levels of myeloperoxidase. Med. Sci. Monit. 14, 406-410.
47. Wiseman, H. (1993) Vitamin D is a membrane antioxidant. Ability to inhibit iron-dependent lipid peroxidation in liposomes compared to cholesterol, ergosterol and tamoxifen and relevance to anticancer action. FEBS Lett. 326, 285-288.
48. Yamagishi, S., Nakamura, K., Matsui, T., Noda, Y. & Imaizumi, T. (2008a) Receptor for advanced glycation end products (RAGE): a novel therapeutic target for diabetic vascular complication. Curr. Pharm. Des. 14, 487-495.
49. Yamagishi, S., Nakamura, K., Matsui, T., Ueda, S., Fukami, K. & Okuda, S. (2008b) Agents that block advanced glycation end product (AGE)-RAGE (receptor for AGEs)-oxidative stress system: a novel therapeutic strategy for diabetic vascular complications. Expert Opin. Investig. Drugs 17, 983-996.
50. Yoshida, N., Okumura, K. & Aso, Y. (2005) High serum pentosidine concentrations are associated with increased arterial stiffness and thickness in patients with type 2 diabetes. Metabolism 54, 345-350.
51. Yuan, W., Pan, W., Kong, J., Zheng, W., Szeto, F.L., Wong, K.E., Cohen, R., Klopot, A., Zhang, Z. & Li, Y.C. (2007) 1, 25-dihydroxyvitamin D3 suppresses renin gene transcription by blocking the activity of the cyclic AMP response element in the renin gene promoter. J. Biol. Chem. 282, 29821-29830.